State of Wyoming - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 196 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
State of Wyoming ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$188,755
+323.0%
2,566
+284.1%
0.06%
+306.7%
Q4 2022$44,622
+346.2%
668
+486.0%
0.02%
+150.0%
Q2 2022$10,000
-75.6%
114
-68.5%
0.01%
-71.4%
Q1 2022$41,000
-51.2%
362
-33.2%
0.02%
-46.2%
Q4 2021$84,000
+68.0%
542
+49.7%
0.04%
+21.9%
Q3 2021$50,000
+257.1%
362
+232.1%
0.03%
+255.6%
Q2 2021$14,0001090.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders